Applications for review of Honeysuckle Health Buying Group authorisation determination [2022] ACompT 3

Applications for review of Honeysuckle Health Buying Group authorisation determination [2022] ACompT 3

The AMA was granted leave to intervene because it had a direct representative interest as the peak professional body for doctors and could usefully address implications of the proposed authorised conduct across the medical profession, including private health insurance arrangements, public benefits, market structure and participation of Major PHIs. The RANZCP and APS were refused leave because, although they represented medical professionals affected by the conduct and may have relevant health-system knowledge, they had not articulated the role they sought to take or shown how they would usefully or relevantly add to or supplement the parties' evidence; their interests would be adequately...

Jurisdiction
Australia
Judgment Date
25 May 2022
Procedural Posture
Applications for Review of Authorisation Determination AA1000542 and Applications for Leave to Intervene / Determined on the Papers
Outcome
The AMA was granted leave to intervene; the RANZCP and APS were refused leave to intervene but permitted to file written submissions.
Legal Topics
['review of ACCC Authorisation Determination' 'intervention in Australian Competition Tribunal Proceedings' 'health Insurance Buying Group' 'collective Contracting']
['competition Law' 'administrative Review'] ['review of ACCC Authorisation Determination' 'intervention in Australian Competition Tribunal Proceedings' 'health Insurance Buying Group' 'collective Contracting']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Applications for Review of Authorisation Determination AA1000542 and Applications for Leave to Intervene / Determined on the Papers

Legal Issues

  1. 1 ['Whether the Australian Medical Association should be granted leave to intervene under s 109(2) of the Competition and Consumer Act 2010 (Cth).' 'Whether the Royal Australian and New Zealand College of Psychiatrists should be granted leave to intervene under s 109(2) of the Competition and Consumer Act 2010 (Cth).' 'Whether the Australian Pain Society Limited should be granted leave to intervene under s 109(2) of the Competition and Consumer Act 2010 (Cth).' 'Whether the RANZCP and APS should instead be permitted to file written submissions as third parties.']

Ratio Decidendi

The AMA was granted leave to intervene because it had a direct representative interest as the peak professional body for doctors and could usefully address implications of the proposed authorised conduct across the medical profession, including private health insurance arrangements, public benefits, market structure and participation of Major PHIs. The RANZCP and APS were refused leave because, although they represented medical professionals affected by the conduct and may have relevant health-system knowledge, they had not articulated the role they sought to take or shown how they would usefully or relevantly add to or supplement the parties' evidence; their interests would be adequately...

Court Disposition

The AMA was granted leave to intervene; the RANZCP and APS were refused leave to intervene but permitted to file written submissions.

Orders

  • ['The Australian Medical Association be granted leave to intervene in the proceeding.' 'The applications by the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and by the Australian Pain Society (APS) for leave to intervene be refused.' 'Each of the RANZCP and the APS be granted leave to file and...